SEC Form 4 · accession 0001127602-19-008788
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Ross Smith
Officer — Corporate Executive VP & CFO
Period of report
Feb 26, 2019
Accepted (ET)
Feb 28, 2019 · 9:21 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 26, 2019 | M | 4,187 | $73.70 | A | 24,270 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $139.32 | D | 24,170 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $139.46 | D | 24,070 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $139.51 | D | 23,970 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $139.56 | D | 23,870 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $139.57 | D | 23,770 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $139.58 | D | 23,670 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $139.59 | D | 23,570 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $139.61 | D | 23,470 | D | |
| Common Stock | Feb 26, 2019 | S | 750 | $139.6184 | D | 22,720 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $139.64 | D | 22,620 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $139.65 | D | 22,520 | D | |
| Common Stock | Feb 26, 2019 | S | 300 | $139.69 | D | 22,220 | D | |
| Common Stock | Feb 26, 2019 | S | 400 | $139.70 | D | 21,820 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $139.75 | D | 21,720 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $139.77 | D | 21,620 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $139.79 | D | 21,520 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $139.80 | D | 21,420 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $139.82 | D | 21,320 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $139.85 | D | 21,220 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $139.88 | D | 21,120 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $139.92 | D | 21,020 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $139.94 | D | 20,920 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $139.98 | D | 20,820 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $140.03 | D | 20,720 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $140.10 | D | 20,620 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $140.19 | D | 20,520 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $140.26 | D | 20,420 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $140.27 | D | 20,320 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $140.30 | D | 20,220 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $73.70 | Feb 26, 2019 | M | 4,187 | D | Feb 26, 2017 | Feb 26, 2021 | Common Stock | 4,187 | 4,188 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.